US Broker Ratings

Madrigal Pharmaceuticals (MDGL) Stock Analysis: Growth Potential in Biotech with a 21.56% Upside

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is making waves in the biotechnology sector, particularly for investors keen on high-growth opportunities. With a market cap of $8.24 billion, this healthcare player is..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: A Biotech Pioneer with an 8.94% Upside Potential

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands out in the biotechnology sector with its focus on developing innovative RNA-targeted therapeutics and gene therapies for rare diseases such as Duchenne muscular dystrophy...

Option Care Health, Inc. (OPCH) Stock Analysis: Unveiling a 36.93% Potential Upside

In the dynamic realm of healthcare, Option Care Health, Inc. (NASDAQ: OPCH) stands out as a significant player within the medical care facilities industry. With a market capitalization of $4.6..

Corcept Therapeutics Inc. (CORT) Stock Analysis: Robust Growth Potential with 87% Upside

Corcept Therapeutics Incorporated (NASDAQ: CORT) stands out as an intriguing prospect in the healthcare sector, specifically within the biotechnology industry. With a market capitalization of $7.56 billion, Corcept Therapeutics is..

Chemed Corp (CHE) Stock Analysis: Uncovering a 27% Potential Upside in the Healthcare Sector

As investors navigate the intricate landscape of healthcare stocks, Chemed Corp (NYSE: CHE) emerges as a compelling candidate with a noteworthy potential upside. With a market capitalization of $6.49 billion,..

Merit Medical Systems, Inc. (MMSI) Stock Analysis: Unlocking a 21% Potential Upside with Strong Buy Ratings

Investors with a keen eye on the healthcare sector might find Merit Medical Systems, Inc. (NASDAQ: MMSI) an intriguing prospect, particularly given its strong market position in the Medical Instruments..

Neurocrine Biosciences, Inc. (NBIX) Stock Analysis: A Promising 26% Upside Potential Awaits Investors

Neurocrine Biosciences, Inc. (NBIX), a pivotal player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, is capturing investor attention with a substantial market cap of..

Bio-Techne Corp (TECH) Stock Analysis: Exploring a 19.69% Potential Upside in the Biotechnology Sector

Bio-Techne Corp (NASDAQ: TECH) is a compelling entity within the biotechnology industry, offering significant opportunities for investors with its innovative product lines and strategic partnerships. Headquartered in Minneapolis, Minnesota, Bio-Techne..

Teleflex Incorporated (TFX) Investor Outlook: Exploring a 16.10% Potential Upside in the Healthcare Sector

Teleflex Incorporated (NYSE: TFX), a prominent player in the healthcare sector, is capturing investor attention with a potential upside of 16.10%, according to recent analyst ratings. Specializing in the design..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Biotech Innovator with Over 63% Potential Upside

Investors with an eye on the healthcare sector might find Soleno Therapeutics, Inc. (SLNO) an intriguing opportunity. The company, headquartered in Redwood City, California, operates within the biotechnology industry and..

Integer Holdings Corporation (ITGR) Stock Analysis: Strong Buy Ratings Signal a Potential 31.92% Upside

For investors scouting opportunities in the healthcare sector, Integer Holdings Corporation (NYSE: ITGR) emerges as a compelling candidate. This Plano, Texas-based medical device manufacturer operates globally, delivering a wide array..

Krystal Biotech, Inc. (KRYS) Investor Outlook: Exploring a 36.75% Potential Upside in Genetic Medicine

Krystal Biotech, Inc. (NASDAQ: KRYS), a pioneering commercial-stage biotechnology firm, is capturing the attention of investors with its promising advancements in genetic medicine and a significant potential upside of 36.75%...

Repligen Corporation (RGEN) Investor Outlook: Analyzing the 44.54% Potential Upside

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, is making waves with its innovative bioprocessing technologies. As the company continues to expand its footprint across North America,..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a Potential 13.67% Upside in the Healthcare Sector

Grifols, S.A. (NASDAQ: GRFS), a key player in the healthcare sector, is garnering attention from investors due to its robust market position and promising growth potential. Headquartered in Barcelona, Spain,..

Hologic, Inc. (HOLX) Stock Analysis: Evaluating the 8.24% Upside Potential in the Healthcare Sector

Hologic, Inc. (NASDAQ: HOLX), a major player in the healthcare sector, stands out for its commitment to women’s health through innovative diagnostics, medical imaging systems, and surgical products. With a..

HealthEquity, Inc. (HQY) Investor Outlook: Analyst Ratings Signal 35.80% Upside Potential

HealthEquity, Inc. (NASDAQ: HQY) stands as a prominent player in the healthcare sector, specifically within the health information services industry. With a substantial market capitalization of $7.77 billion, the company..

Revvity, Inc. (RVTY) Stock Analysis: 28.68% Upside Potential and Strong Buy Ratings Signal Growth

Revvity, Inc. (RVTY), formerly known as PerkinElmer, Inc., presents a compelling investment opportunity in the healthcare sector with its diversified offerings in diagnostics and research. With a market cap of..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Evaluating the 7.82% Upside Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, is a name that resonates with innovation and resilience in the pharmaceutical industry. Headquartered in Hyderabad, India,..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: A 54% Upside Potential in the Biotechnology Sector

Akero Therapeutics, Inc. (NASDAQ: AKRO) has captured the attention of investors with its promising developments in the biotechnology sector. Specializing in treatments for metabolic diseases, the company is currently focused..

Molina Healthcare Inc (MOH) Stock Analysis: Uncovering a 20% Upside Potential in the Healthcare Sector

Molina Healthcare Inc (NYSE: MOH), a leading provider of managed healthcare services, presents an intriguing opportunity for individual investors seeking exposure to the healthcare sector. With a notable 20.22% potential..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds